Action CMH CHORDATE MEDICAL HOLDING AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Chordate Medical Holding AB

Actions

CMH

SE0009495559

Marché Fermé - Nasdaq Stockholm
Autres places de cotation
 17:29:45 31/05/2024 		Varia. 5j. Varia. 1 janv.
0,0522 SEK -2,97% Graphique intraday de Chordate Medical Holding AB +6,10% -67,46%
24/05 Chordate Medical Holding AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
07/05 Chordate Medical obtient l'approbation d'un brevet aux États-Unis CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Kalqyl in updated Analysis of Chordate Medical: "Making Progress in All Areas of the Market Plan"
AQ
Chordate Medical's CEO to BioStock: "We are building step by step"
AQ
Chordate Medical Presents at The Global Forum by Biostock 2024
AQ
Finwire Interview: CEO Anders Weilandt on Chordate Medical’s Q1 Report
AQ
Chordate Medical Holding AB (publ) Interim Report January-March 2024
AQ
Chordate Medical presents interim report for Q1 2024 on Finwire TV
AQ
Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)
AQ
Chordate Presents Ozilia at Pharma Partnering EU Summit 2024
AQ
BioStock: Chordate Medical receives patent approval in the US
AQ
Chordate will be granted a fourth patent in the USA
AQ
Chordate's board member to BioStock: "Women's health is a concern for society at large"
AQ
Chordate presents Ozilia at LSX World Congress on April 29-30
AQ
Chordate presents Ozilia to national specialist associations from Germany, Switzerland, & Austria
AQ
Chordate presents at the Feminvest investor conference in Oslo
AQ
Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider
AQ
Notice to the Annual General Meeting in Chordate Medical Holding AB (publ)
AQ
Chordate Medical Holding AB publishes annual report for 2023
AQ
BioStock: Chordate comments on Q4 and case report
AQ
Chordate Medical's CEO Anders Weilandt interviewed about year-end report by Finwire
AQ
Year-End Report Chordate Medical Holding AB (publ) January - December 2023
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CMH
  4. Actualités Chordate Medical Holding AB
  5. Communiqués
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT